TMills
TMills t1_j8eh61k wrote
Reply to [D] Is a non-SOTA paper still good to publish if it has an interesting method that does have strong improvements over baselines (read text for more context)? Are there good examples of this kind of work being published? by orangelord234
It doesn't need to be sota in an absolute sense, but it should be interesting in an empirical way. If the model is small, it needs to benchmark against other small models. If it's efficient it should compare against other efficient models. If you just like it aesthetically, or think it's clever, then you need to think about what that cleverness buys you and evaluate it in that dimension.
TMills t1_ittkwez wrote
Reply to Can someone explain the ethics of testing potentially life saving medication? by beatleboy07
In addition to some of the other great comments here, it's helpful to adjust your prior beliefs about new treatments we are testing. Even with promising pre-trial data, many will not work in humans, most that do have only slight benefits, and only rarely do we see large benefits. And almost all have some potential side effects. So whatever the control is (placebo or standard of care), it's often not the "worse" arm.
TMills t1_je3fnft wrote
Reply to comment by LightWise6702 in Does anyone have any problems bringing their e-bike on the commuter rail by LightWise6702
You’ll be making these cool employees jobs harder and congesting the crowded train entrance if you take one of the trains thats not meant for bikes.